Author:
Kluth L.A.,Rink M.,Ahyai S.A.,Fisch M.,Shariat S.F.,Dahm P.
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Poldermans D, Boersma E, Bax JJ et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341(24):1789–1794
2. Berghe G van den, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367
3. National Institute for Health and Clinical Excellence (2009) Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal. Guidance 169. NICE, London, http://guidance.nice.org.uk. Zugegriffen: June 2010
4. Attard G, Belldegrun AS, Bono JS de (2005) Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer. BJU Int 96(9):1241–1246
5. Bono JS de, Logothetis CJ, Molina A et al (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364(21):1995–2005